← Leaderboards
Elizabeth A Grimm
University Of Texas Md Anderson Can Ctr
$11,275,665
Attributed
$11,275,665
Total exposure
16
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4M · FY2005–21$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$34,932,965 · 17
By mechanism
P50$30,285,987 · 12
R42$1,846,876 · 1
R01$1,328,726 · 1
R41$1,047,218 · 2
T32$424,158 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Md Anderson Can Ctr
Same institution · by research overlap
- Menashe Bareli$6,643,202
- Roy S Herbst$12,300,874
- Vinay K Puduvalli$3,692,967
- Peter F Thall$4,683,294
- Karen Hsieh Lu$10,934,889
Others in their field
Top investigators on “Melanoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$206,517,726
- Richard L Schilsky · University Of Chicago$108,377,382
- Larry Arthur$59,113,709
- Charles A Coltman · Southwest Oncology Group$55,198,633
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$47,956,689
- Meenhard Herlyn · University Of Pennsylvania$46,448,742
Research focus
MelanomaBaseProgramsResearch PersonnelUniversity Of Texas M D Anderson Cancer CenterFundingInnovationTranslational ResearchLaboratoriesClinical ResearchDesignBiologyBudgetsDoctor Of MedicineSkin CancerAwardInstitutionReportingMonitorGrantResourcesScientistMeetingsSuccess
Grant awards (78)
Career Enhancement Program$89,364
P50 · FY2021 · CA · contact PI
Development Research Program$89,364
P50 · FY2021 · CA · contact PI
Career Enhancement Program$169,979
P50 · FY2020 · CA · contact PI
Development Research Program$118,139
P50 · FY2020 · CA · contact PI
Development Research Program$95,771
P50 · FY2019 · CA · contact PI
Career Enhancement Program$95,771
P50 · FY2019 · CA · contact PI
The University of Texas M. D. Anderson Cancer Center SPORE in Melanoma$2,133,882
P50 · FY2014 · CA · contact PI
Administration, Evaluation, and Planning$186,777
P50 · FY2014 · CA · contact PI
Prognostic Significance and Targeting of an iNOS-Associated Human Melanoma$139,875
P50 · FY2014 · CA · contact PI
Career Development Program$61,245
P50 · FY2014 · CA · contact PI
Development Research Program$59,393
P50 · FY2014 · CA · contact PI
The University of Texas M. D. Anderson Cancer Center SPORE in Melanoma$2,150,500
P50 · FY2013 · CA · contact PI
Administration, Evaluation, and Planning$292,405
P50 · FY2013 · CA · contact PI
Prognostic Significance and Targeting of an iNOS-Associated Human Melanoma$236,788
P50 · FY2013 · CA · contact PI
Development Research Program$142,012
P50 · FY2013 · CA · contact PI
Career Development Program$142,010
P50 · FY2013 · CA · contact PI
The University of Texas M. D. Anderson Cancer Center SPORE in Melanoma$2,272,914
P50 · FY2012 · CA · contact PI
Administration, Evaluation, and Planning$242,312
P50 · FY2012 · CA · contact PI
Prognostic Significance and Targeting of an iNOS-Associated Human Melanoma$182,544
P50 · FY2012 · CA · contact PI
Career Development Program$78,975
P50 · FY2012 · CA · contact PI
Development Research Program$78,975
P50 · FY2012 · CA · contact PI
The University of Texas M. D. Anderson Cancer Center SPORE in Melanoma$2,185,000
P50 · FY2011 · CA · contact PI
Administration, Evaluation, and Planning$201,132
P50 · FY2011 · CA · contact PI
Prognostic Significance and Targeting of an iNOS-Associated Human Melanoma$151,987
P50 · FY2011 · CA · contact PI
The University of Texas M. D. Anderson Cancer Center SPORE in Melanoma$87,090
P50 · FY2011 · CA · contact PI
Development Research Program$65,353
P50 · FY2011 · CA · contact PI
Career Development Program$65,352
P50 · FY2011 · CA · contact PI
The University of Texas M. D. Anderson Cancer Center SPORE in Melanoma$2,300,000
P50 · FY2010 · CA · contact PI
Administration, Evaluation, and Planning$211,467
P50 · FY2010 · CA · contact PI
Prognostic Significance and Targeting of an iNOS-Associated Human Melanoma$160,292
P50 · FY2010 · CA · contact PI
Career Development Program$68,492
P50 · FY2010 · CA · contact PI
Development Research Program$68,492
P50 · FY2010 · CA · contact PI
UT M.D. Anderson Cancer Center SPORE in Melanoma$1,079,303
P50 · FY2009 · CA · contact PI
UT M.D. Anderson Cancer Center SPORE in Melanoma$246,751
P50 · FY2009 · CA · contact PI
UT M.D. Anderson Cancer Center SPORE in Melanoma$2,158,606
P50 · FY2008 · CA · contact PI
DEVELOPMENTAL RESEARCH PROGRAM$247,372
P50 · FY2008 · CA · contact PI
PROGNOSTIC SIGNIFICANCE AND ANALYSIS OF iNOS IN MELANOMA$220,233
P50 · FY2008 · CA · contact PI
CAREER DEVELOPMENT$185,534
P50 · FY2008 · CA · contact PI
CORE--BIOSTATISTICS$82,114
P50 · FY2008 · CA · contact PI
UT M.D. Anderson Cancer Center SPORE in Melanoma$2,158,606
P50 · FY2007 · CA · contact PI
DEVELOPMENTAL RESEARCH PROGRAM$254,432
P50 · FY2007 · CA · contact PI
PROGNOSTIC SIGNIFICANCE AND ANALYSIS OF iNOS IN MELANOMA$226,517
P50 · FY2007 · CA · contact PI
CAREER DEVELOPMENT$190,827
P50 · FY2007 · CA · contact PI
CORE--BIOSTATISTICS$84,453
P50 · FY2007 · CA · contact PI
UT M.D. Anderson Cancer Center SPORE in Melanoma$61,594
P50 · FY2007 · CA · contact PI
UT M.D. Anderson Cancer Center SPORE in Melanoma$2,223,770
P50 · FY2006 · CA · contact PI
Gene Therapy for Human Malignant Melanoma$300,183
R42 · FY2006 · CA · contact PI
Heterogeneity of Human Melanoma, Cytokines and iNOS$260,726
R01 · FY2006 · CA · contact PI
DEVELOPMENTAL RESEARCH PROGRAM$176,818
P50 · FY2006 · CA · contact PI
PROGNOSTIC SIGNIFICANCE AND ANALYSIS OF iNOS IN MELANOMA$157,419
P50 · FY2006 · CA · contact PI
CAREER DEVELOPMENT$132,614
P50 · FY2006 · CA · contact PI
CORE--BIOSTATISTICS$58,685
P50 · FY2006 · CA · contact PI
UT M.D. Anderson Cancer Center SPORE in Melanoma$2,277,284
P50 · FY2005 · CA
Gene Therapy for Human Malignant Melanoma$598,308
R42 · FY2005 · CA
WP760 for Malignant Melanoma Therapy$300,000
R41 · FY2005 · CA
Heterogeneity of Human Melanoma, Cytokines and iNOS$267,000
R01 · FY2005 · CA
DEVELOPMENTAL RESEARCH PROGRAM$176,818
P50 · FY2005 · CA
PROGNOSTIC SIGNIFICANCE AND ANALYSIS OF iNOS IN MELANOMA$157,419
P50 · FY2005 · CA
CAREER DEVELOPMENT$132,614
P50 · FY2005 · CA
CORE--BIOSTATISTICS$58,685
P50 · FY2005 · CA
UT M.D. Anderson Cancer Center SPORE in Melanoma$2,300,000
P50 · FY2004 · CA
Gene Therapy for Human Malignant Melanoma$606,567
R42 · FY2004 · CA
Heterogeneity of Human Melanoma, Cytokines and iNOS$267,000
R01 · FY2004 · CA
WP760 for Malignant Melanoma Therapy$254,615
R41 · FY2004 · CA
DEVELOPMENTAL RESEARCH PROGRAM$176,818
P50 · FY2004 · CA
PROGNOSTIC SIGNIFICANCE AND ANALYSIS OF iNOS IN MELANOMA$157,419
P50 · FY2004 · CA
CAREER DEVELOPMENT$132,614
P50 · FY2004 · CA
CORE--BIOSTATISTICS$65,492
P50 · FY2004 · CA
CORE A ADMINISTRATION$59,524
P50 · FY2004 · CA
UT M.D. Anderson Cancer Center SPORE in Melanoma$22,000
P50 · FY2004 · CA
Gene Therapy for Human Malignant Melanoma$341,818
R42 · FY2003 · CA
Heterogeneity of Human Melanoma, Cytokines and iNOS$267,000
R01 · FY2003 · CA
Heterogeneity of Human Melanoma, Cytokines and iNOS$267,000
R01 · FY2002 · CA
GENE THERAPY FOR HUMAN MALIGNANT MELANOMA$245,250
R41 · FY2002 · CA
TRAINING IN CANCER BIOLOGY$149,656
T32 · FY2002 · CA
GENE THERAPY FOR HUMAN MALIGNANT MELANOMA$247,353
R41 · FY2001 · CA
TRAINING IN CANCER BIOLOGY$143,868
T32 · FY2001 · CA
TRAINING IN CANCER BIOLOGY$130,634
T32 · FY2000 · CA